肝癌诊断市场概况、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPRE00003017
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Liver Cancer Diagnostics Market Growth Report by 2031

Buy Now

预计肝癌诊断市场规模将从 2023 年的 107.8 亿美元增至 2031 年的 205.7 亿美元。预计 2023-2031 年期间市场复合年增长率为 8.4%。新技术的不断涌现可能仍是市场的主要趋势。

肝癌诊断市场分析

根据疾病预防控制中心的数据,美国每年约有 24,500 名男性和 10,000 名女性患肝癌,其中 18,600 名男性和 9,000 名女性死于该疾病。几十年来,美国人患肝癌的病例一直在增加。肝细胞癌 (HCC) 是美国最常见的肝癌。此外,根据加拿大政府的数据,目前大约四分之一的加拿大成年人 (26.6%) 患有肥胖症。肥胖病例也在增加,随着病例的增加,患某些健康问题(如肝损伤、糖尿病、高血压和心脏病)的风险也在增加。

肝癌诊断市场概况

世界卫生组织(WHO)表示,2020年全球有超过1000万人死亡,其中每6人中就有1人死于癌症。此外,2020年,肝癌是最常见的癌症类型之一,约占所有新癌症病例的4.7%和所有癌症死亡人数的8.3%。在所有确诊的肝癌病例中,75%到90%是肝细胞癌(HCC),对癌症相关死亡的影响更为显著。根据CCO(中国临床肿瘤学)发表的文章,肝细胞癌(HCC)是全球癌症死亡的首要原因。HCC筛查最常用的方法是血清甲胎蛋白(AFP)测试和肝脏超声检查。但就敏感度而言,AFP测试的敏感度为25%到65%,超声的敏感度超过60%。肝癌是一种较为常见的癌症,病例呈上升趋势。例如,在英国,到 2025 年,肝细胞癌的死亡率预计将上升 14%,是所有癌症中增幅最大的。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

肝癌诊断市场:

肝癌诊断市场
  • Liver Cancer Diagnostics Market
    复合年增长率(2023 - 2031)
    8.4%
  • 2023 年市场规模
    107.8 亿美元
  • 2031年市场规模
    205.7亿美元

市场动态

增长动力
  • 通过战略举措提高诊断率
  • 肝癌病例增加
未来的趋势
  • 新技术不断涌现是趋势
机会
  • 增加研发支出

关键人物;主力;重要一员

  • 雅培,
  • 生物梅里埃公司, SA,
  • F.霍夫曼-拉罗氏有限公司,HOFFMANN-LA ROCHE LTD,
  • Illumina 公司, Inc.,
  • 荷兰皇家飞利浦公司, Philips N.V,
  • QIAGEN,,
  • 西门子医疗股份公司,Healthineers AG,
  • 赛默飞世尔科技股份有限公司 FISHER SCIENTIFIC INC.,
  • 通用电气医疗集团
  • 视角,

区域概况

Liver Cancer Diagnostics Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Liver Cancer Diagnostics Market类型
  • 实验室检查
  • 内窥镜检查
  • 影像
  • 活检
Liver Cancer Diagnostics Market最终用户
  • 医院和诊断实验室
  • 学术及研究机构
  • CRO实验室
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

肝癌诊断市场驱动因素和机遇

由于战略举措有利于市场,诊断率不断提高

2020 年 6 月,NCI 科学家开发了一种用于筛查肝细胞癌 (HCC)(最常见的肝癌形式)的新检测方法。该筛查方法包括血液检测,以调查患者之前是否接触过某些病毒。这种筛查可以实现早期发现和诊断,主要是因为可以检测到晚期或晚期癌症,而到那时,这些癌症通常已经无法治愈。此外,NCI 还启动了 CCR 肝癌计划,以开发早期发现、诊断和治疗的新方法,旨在改善 HCC 患者的治疗效果。此外,美国国立卫生研究院 (NIH) 启动了其临床试验网络,以评估有前景的新癌症筛查技术可能带来的帮助和问题,并管理将这些创新整合到标准护理方案中的有效方法。

增加研发支出

2021 年,Elecsys GALAD 研发 (R&D) 支出为 146.5 亿美元,2020 年为 131.7 亿美元。核心支出增长了 14%。此外,F. Hoffmann-La Roche Ltd 的研发支出增加,主要用于肿瘤学、眼科和个性化医疗的后期投资。此外,2020 年 6 月,美国国立卫生研究院 (NIH) 的科学家推出了血液检测,以改善肝癌筛查,这些检测由美国国家癌症研究所 (NCI) 的研究人员管理。因此,不断增加的研发投资和肝癌诊断测试的发展正在推动肝癌诊断市场的发展。

肝癌诊断市场报告细分分析

有助于得出肝癌诊断市场分析的关键部分是类型和最终用户。

  • 根据类型,市场分为实验室测试、内窥镜检查、成像、活检等。实验室测试部分在 2023 年占据了更大的市场份额。
  • 根据最终用户,市场分为医院和诊断实验室、学术和研究机构以及 CRO 实验室。医院和诊断实验室部门在 2023 年占据了更大的市场份额。

肝癌诊断市场份额按地区分析

肝癌诊断市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。

北美占据市场主导地位,预计亚太地区未来几年将以最高的复合年增长率增长。亚太市场的增长归因于老年人口的增加和肝癌治疗选择的扩大。由于印度和中国等国家实施了改进的肝癌诊断程序,预计亚太地区的复合年增长率最高。随着诊断解决方案成本效益的提高,预计亚太地区独立诊断实验室对肝癌诊断的需求将上升。上述因素将推动肝癌诊断市场的发展。

肝癌诊断市场报告范围

报告属性细节
2023 年的市场规模107.8亿美元
2031 年市场规模205.7亿美元
全球复合年增长率(2023 - 2031)8.4%
历史数据2021-2022
预测期2024-2031
涵盖的领域按类型
  • 实验室检查
  • 内窥镜检查
  • 影像
  • 活检
按最终用户
  • 医院和诊断实验室
  • 学术及研究机构
  • CRO实验室
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 雅培,
  • 生物梅里埃公司,
  • F.霍夫曼-拉罗氏有限公司,
  • Illumina 公司
  • 荷兰皇家飞利浦公司,
  • QIAGEN,
  • 西门子医疗股份公司,
  • 赛默飞世尔科技股份有限公司
  • 通用电气医疗集团
  • 视角,
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

肝癌诊断市场新闻和最新发展

肝癌诊断市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。下面列出了肝癌诊断市场的一些发展情况:

  • Illumina, Inc. 推出了 TruSight 肿瘤学测试,用于评估多种肿瘤基因和生物标志物。TruSight 测试将很快在欧洲开始全球推出。它评估肿瘤基因和生物标志物,以发现患者癌症的特定分子特征,帮助为精准医疗决策提供信息。(来源:Illumina, Inc.,新闻稿,2022 年 3 月)
  • Perspectum 与 HepQuant 建立合作伙伴关系,通过 Perspectum 的合同研究组织 (CRO) 服务提供 HepQuant 的肝功能评估技术。此次合作使支持肝病临床试验的制药公司(包括肝硬化、非酒精性脂肪性肝炎 (NASH)、自身免疫性肝病和肝癌)能够从 Perspectum 的 Pharma Solutions 获得成像和功能测试知识。(来源:Perspectum,新闻稿,2021 年 11 月)

肝癌诊断市场报告覆盖范围和交付成果

“肝癌诊断市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 肝癌诊断市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 肝癌诊断市场趋势,以及驱动因素、限制因素和关键机遇等市场动态
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 肝癌诊断市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展3
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及肝癌诊断市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the liver cancer diagnostics market in 2023?

North America has dominated the Liver Cancer Diagnostics market.

What are the driving factors impacting the liver cancer diagnostics market?

Factors such as increasing diagnosis due to strategic initiatives and incasering liver cancer cases will boost the market growth.

What are the future trends of the liver cancer diagnostics market?

The rising emergence of new technologies is likely to remain a key trend in the market.

What would be the estimated value of the liver cancer diagnostics market by 2031?

The liver cancer diagnostics market size is projected to reach US$ 20.57 billion by 2031.

What is the expected CAGR of the liver cancer diagnostics market?

The market is expected to register a CAGR of 8.4% during 2023–2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..